GEG Q1 2026 Earnings Significant EPS Miss Pressures Stock ICMB Q3 2025 Earnings EPS Falls Short of Estimates Stock Edges Higher BILL Q1 2026 Earnings EPS Surpasses Estimates by Nearly 20 on Operational Discipline Sweetgreen Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains on Operational Momentum vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline